Clinova.Solutions Unveils Turnkey Telehealth Infrastructure in Partnership with Medtech and Biotech Leaders to Accelerate Market Entry

Image credit: Photo and Image provided by Clinova.Solutions

Editorial Brief
At a glance: AI-assisted overview, optimised for journalists, search & news aggregators
Press Release

September 5, 2025

Clinova.Solutions has announced a new ability to partner with leading medtech and biotech innovators to deliver a turnkey telehealth infrastructure designed to accelerate the path to patient access. Built specifically for organizations looking to expand beyond traditional distribution barriers, the platform creates an immediate opportunity for innovators to bring their devices and diagnostics directly to market with a nationwide, compliant framework.

This partnership model provides medtech and biotech companies with a faster, lower-risk pathway to commercialization by integrating regulatory oversight, nationwide licensing, and clinical coverage into a single solution. Rather than building infrastructure state by state, partners can leverage Clinova.Solutions’ established network to launch and scale digital health offerings within weeks, saving time, reducing administrative burden, and reaching patients without delay.

The infrastructure combines asynchronous care, patient-initiated intake, secure messaging, and prescription management with comprehensive oversight across all 50 states, serving both adult and pediatric populations. By offering flexible coverage blocks, Clinova.Solutions ensures partners can scale at the pace of adoption, aligning costs with growth and maximizing return on investment.

Through this new ability to partner, innovators can move quickly once FDA approved in the US, bypassing payer delays, overcoming administrative bottlenecks, and reaching patients with safe, effective solutions. Partners also gain real-world evidence through ongoing patient engagement and monitoring, creating a data-driven advantage for reimbursement, clinical validation, and market expansion.

Clinova.Solutions is actively seeking new partnerships with companies aiming to deliver medical devices, diagnostics, and digital health tools directly to patients through asynchronous care models. By engaging in partnership, medtech and biotech innovators can integrate seamlessly into a nationwide framework that delivers direct provider services, expands patient access, and strengthens long-term adoption through real-world outcomes.

Organizations interested in exploring partnership opportunities with Clinova.Solutions are encouraged to connect directly through the company’s website or schedule a strategy session with the leadership team to discuss tailored pathways for device access, diagnostic delivery, and nationwide telehealth integration.

Notes to editors

About Clinova.Solutions Dr. Jasmine Bonder, DNP, MSN, ACNP-BC, RN, is the Founder and CEO of Clinova.Solutions, a nationwide platform that partners with biotech and medtech companies to launch asynchronous telemedicine services. Under her leadership, Clinova.Solutions delivers scalable, compliant clinical operations that accelerate market entry, expand patient access, and support innovation across the healthcare ecosystem. Dr. Adam Bonder, MD, MBA, is the Medical Director of Clinova.Solutions, overseeing nationwide telemedicine initiatives that integrate asynchronous care with scalable clinical operations. Through his combined expertise in emergency medicine and business strategy, Clinova.Solutions drives strategic growth, operational efficiency, and the development of sustainable healthcare models that align medical innovation with long-term market success.

Get more news like this

Get more news like this on Google. Set News By Wire as a ‘Preferred News Source’ to get quicker access to news that’s important.

All done!
Thank you for subscribing.

Email Subscription